ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Theraputics Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-7S13754
Home | Market Reports | Computers & Electronics| Software
Global Cell Theraputics Market Research Report 2023
BUY CHAPTERS

Global Cell Theraputics Market Research Report 2025

Code: QYRE-Auto-7S13754
Report
June 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol-Myers Squibb Company (Celgene)
Bluebird bio
CRISPR Therapeutics
Roche (Spark Therapeutics)
PTC Therapeutics
Moderna Therapeutics
Quanterix
Brainstorm Cell Therapeutics Inc.
Lineage Cell Therapeutics
CTI BioPharma
Atara Biotherapeutics Inc
Adaptimmune
Novartis
Gilead Sciences
Juno Therapeutics
Takeda Pharmaceuticals
Celgene
Adaptimmune Therapeutics
CARsgen Therapeutics
Precision Biosciences
Sangamo Therapeutics

Cell Theraputics Market

The global market for Cell Theraputics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell theraputics are therapies in which cellular material is injected, grafted or implanted into a patient, mostly intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
North American market for Cell Theraputics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Theraputics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Theraputics in Allogeneic Cell Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Theraputics include Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Cti Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Theraputics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Theraputics.
The Cell Theraputics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Theraputics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Theraputics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Theraputics Market Report

Report Metric Details
Report Name Cell Theraputics Market
Segment by Type
  • Stem Cells
  • Immunocyte
Segment by Application
  • Allogeneic Cell Therapy
  • Autologous Cell Therapy
  • Xenogeneic Cell Therapy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Cti Biopharma, Atara Biotherapeutics, Inc, Adaptimmune, Novartis, Gilead Sciences, Juno Therapeutics, Takeda Pharmaceuticals, Celgene, Adaptimmune Therapeutics, CARsgen Therapeutics, Precision Biosciences, Sangamo Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Theraputics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell Theraputics Market report?

Ans: The main players in the Cell Theraputics Market are Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Cti Biopharma, Atara Biotherapeutics, Inc, Adaptimmune, Novartis, Gilead Sciences, Juno Therapeutics, Takeda Pharmaceuticals, Celgene, Adaptimmune Therapeutics, CARsgen Therapeutics, Precision Biosciences, Sangamo Therapeutics

What are the Application segmentation covered in the Cell Theraputics Market report?

Ans: The Applications covered in the Cell Theraputics Market report are Allogeneic Cell Therapy, Autologous Cell Therapy, Xenogeneic Cell Therapy

What are the Type segmentation covered in the Cell Theraputics Market report?

Ans: The Types covered in the Cell Theraputics Market report are Stem Cells, Immunocyte

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Theraputics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cells
1.2.3 Immunocyte
1.3 Market by Application
1.3.1 Global Cell Theraputics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Allogeneic Cell Therapy
1.3.3 Autologous Cell Therapy
1.3.4 Xenogeneic Cell Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Theraputics Market Perspective (2020-2031)
2.2 Global Cell Theraputics Growth Trends by Region
2.2.1 Global Cell Theraputics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Theraputics Historic Market Size by Region (2020-2025)
2.2.3 Cell Theraputics Forecasted Market Size by Region (2026-2031)
2.3 Cell Theraputics Market Dynamics
2.3.1 Cell Theraputics Industry Trends
2.3.2 Cell Theraputics Market Drivers
2.3.3 Cell Theraputics Market Challenges
2.3.4 Cell Theraputics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Theraputics Players by Revenue
3.1.1 Global Top Cell Theraputics Players by Revenue (2020-2025)
3.1.2 Global Cell Theraputics Revenue Market Share by Players (2020-2025)
3.2 Global Cell Theraputics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Theraputics Revenue
3.4 Global Cell Theraputics Market Concentration Ratio
3.4.1 Global Cell Theraputics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Theraputics Revenue in 2024
3.5 Global Key Players of Cell Theraputics Head office and Area Served
3.6 Global Key Players of Cell Theraputics, Product and Application
3.7 Global Key Players of Cell Theraputics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Theraputics Breakdown Data by Type
4.1 Global Cell Theraputics Historic Market Size by Type (2020-2025)
4.2 Global Cell Theraputics Forecasted Market Size by Type (2026-2031)
5 Cell Theraputics Breakdown Data by Application
5.1 Global Cell Theraputics Historic Market Size by Application (2020-2025)
5.2 Global Cell Theraputics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Theraputics Market Size (2020-2031)
6.2 North America Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Theraputics Market Size by Country (2020-2025)
6.4 North America Cell Theraputics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Theraputics Market Size (2020-2031)
7.2 Europe Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Theraputics Market Size by Country (2020-2025)
7.4 Europe Cell Theraputics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Theraputics Market Size (2020-2031)
8.2 Asia-Pacific Cell Theraputics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Theraputics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Theraputics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Theraputics Market Size (2020-2031)
9.2 Latin America Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Theraputics Market Size by Country (2020-2025)
9.4 Latin America Cell Theraputics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Theraputics Market Size (2020-2031)
10.2 Middle East & Africa Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Theraputics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Theraputics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company (Celgene)
11.1.1 Bristol-Myers Squibb Company (Celgene) Company Details
11.1.2 Bristol-Myers Squibb Company (Celgene) Business Overview
11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Introduction
11.1.4 Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2020-2025)
11.1.5 Bristol-Myers Squibb Company (Celgene) Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Cell Theraputics Introduction
11.2.4 Bluebird Bio Revenue in Cell Theraputics Business (2020-2025)
11.2.5 Bluebird Bio Recent Development
11.3 Crispr Therapeutics
11.3.1 Crispr Therapeutics Company Details
11.3.2 Crispr Therapeutics Business Overview
11.3.3 Crispr Therapeutics Cell Theraputics Introduction
11.3.4 Crispr Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.3.5 Crispr Therapeutics Recent Development
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Details
11.4.2 Roche (Spark Therapeutics) Business Overview
11.4.3 Roche (Spark Therapeutics) Cell Theraputics Introduction
11.4.4 Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2020-2025)
11.4.5 Roche (Spark Therapeutics) Recent Development
11.5 PTC Therapeutics
11.5.1 PTC Therapeutics Company Details
11.5.2 PTC Therapeutics Business Overview
11.5.3 PTC Therapeutics Cell Theraputics Introduction
11.5.4 PTC Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.5.5 PTC Therapeutics Recent Development
11.6 Moderna Therapeutics
11.6.1 Moderna Therapeutics Company Details
11.6.2 Moderna Therapeutics Business Overview
11.6.3 Moderna Therapeutics Cell Theraputics Introduction
11.6.4 Moderna Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.6.5 Moderna Therapeutics Recent Development
11.7 Quanterix
11.7.1 Quanterix Company Details
11.7.2 Quanterix Business Overview
11.7.3 Quanterix Cell Theraputics Introduction
11.7.4 Quanterix Revenue in Cell Theraputics Business (2020-2025)
11.7.5 Quanterix Recent Development
11.8 Brainstorm Cell Therapeutics Inc.
11.8.1 Brainstorm Cell Therapeutics Inc. Company Details
11.8.2 Brainstorm Cell Therapeutics Inc. Business Overview
11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Introduction
11.8.4 Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2020-2025)
11.8.5 Brainstorm Cell Therapeutics Inc. Recent Development
11.9 Lineage Cell Therapeutics
11.9.1 Lineage Cell Therapeutics Company Details
11.9.2 Lineage Cell Therapeutics Business Overview
11.9.3 Lineage Cell Therapeutics Cell Theraputics Introduction
11.9.4 Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.9.5 Lineage Cell Therapeutics Recent Development
11.10 Cti Biopharma
11.10.1 Cti Biopharma Company Details
11.10.2 Cti Biopharma Business Overview
11.10.3 Cti Biopharma Cell Theraputics Introduction
11.10.4 Cti Biopharma Revenue in Cell Theraputics Business (2020-2025)
11.10.5 Cti Biopharma Recent Development
11.11 Atara Biotherapeutics, Inc
11.11.1 Atara Biotherapeutics, Inc Company Details
11.11.2 Atara Biotherapeutics, Inc Business Overview
11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Introduction
11.11.4 Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2020-2025)
11.11.5 Atara Biotherapeutics, Inc Recent Development
11.12 Adaptimmune
11.12.1 Adaptimmune Company Details
11.12.2 Adaptimmune Business Overview
11.12.3 Adaptimmune Cell Theraputics Introduction
11.12.4 Adaptimmune Revenue in Cell Theraputics Business (2020-2025)
11.12.5 Adaptimmune Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Cell Theraputics Introduction
11.13.4 Novartis Revenue in Cell Theraputics Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Cell Theraputics Introduction
11.14.4 Gilead Sciences Revenue in Cell Theraputics Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
11.15 Juno Therapeutics
11.15.1 Juno Therapeutics Company Details
11.15.2 Juno Therapeutics Business Overview
11.15.3 Juno Therapeutics Cell Theraputics Introduction
11.15.4 Juno Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.15.5 Juno Therapeutics Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Details
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Cell Theraputics Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2020-2025)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Celgene
11.17.1 Celgene Company Details
11.17.2 Celgene Business Overview
11.17.3 Celgene Cell Theraputics Introduction
11.17.4 Celgene Revenue in Cell Theraputics Business (2020-2025)
11.17.5 Celgene Recent Development
11.18 Adaptimmune Therapeutics
11.18.1 Adaptimmune Therapeutics Company Details
11.18.2 Adaptimmune Therapeutics Business Overview
11.18.3 Adaptimmune Therapeutics Cell Theraputics Introduction
11.18.4 Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.18.5 Adaptimmune Therapeutics Recent Development
11.19 CARsgen Therapeutics
11.19.1 CARsgen Therapeutics Company Details
11.19.2 CARsgen Therapeutics Business Overview
11.19.3 CARsgen Therapeutics Cell Theraputics Introduction
11.19.4 CARsgen Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.19.5 CARsgen Therapeutics Recent Development
11.20 Precision Biosciences
11.20.1 Precision Biosciences Company Details
11.20.2 Precision Biosciences Business Overview
11.20.3 Precision Biosciences Cell Theraputics Introduction
11.20.4 Precision Biosciences Revenue in Cell Theraputics Business (2020-2025)
11.20.5 Precision Biosciences Recent Development
11.21 Sangamo Therapeutics
11.21.1 Sangamo Therapeutics Company Details
11.21.2 Sangamo Therapeutics Business Overview
11.21.3 Sangamo Therapeutics Cell Theraputics Introduction
11.21.4 Sangamo Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.21.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bristol-Myers Squibb Company (Celgene)
Bluebird bio
CRISPR Therapeutics
Roche (Spark Therapeutics)
PTC Therapeutics
Moderna Therapeutics
Quanterix
Brainstorm Cell Therapeutics Inc.
Lineage Cell Therapeutics
CTI BioPharma
Atara Biotherapeutics Inc
Adaptimmune
Novartis
Gilead Sciences
Juno Therapeutics
Takeda Pharmaceuticals
Celgene
Adaptimmune Therapeutics
CARsgen Therapeutics
Precision Biosciences
Sangamo Therapeutics
List of Tables
 Table 1. Global Cell Theraputics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stem Cells
 Table 3. Key Players of Immunocyte
 Table 4. Global Cell Theraputics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cell Theraputics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell Theraputics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cell Theraputics Market Share by Region (2020-2025)
 Table 8. Global Cell Theraputics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cell Theraputics Market Share by Region (2026-2031)
 Table 10. Cell Theraputics Market Trends
 Table 11. Cell Theraputics Market Drivers
 Table 12. Cell Theraputics Market Challenges
 Table 13. Cell Theraputics Market Restraints
 Table 14. Global Cell Theraputics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cell Theraputics Market Share by Players (2020-2025)
 Table 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2024)
 Table 17. Ranking of Global Top Cell Theraputics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cell Theraputics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cell Theraputics, Headquarters and Area Served
 Table 20. Global Key Players of Cell Theraputics, Product and Application
 Table 21. Global Key Players of Cell Theraputics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell Theraputics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cell Theraputics Revenue Market Share by Type (2020-2025)
 Table 25. Global Cell Theraputics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cell Theraputics Revenue Market Share by Type (2026-2031)
 Table 27. Global Cell Theraputics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cell Theraputics Revenue Market Share by Application (2020-2025)
 Table 29. Global Cell Theraputics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cell Theraputics Revenue Market Share by Application (2026-2031)
 Table 31. North America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cell Theraputics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cell Theraputics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cell Theraputics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bristol-Myers Squibb Company (Celgene) Company Details
 Table 47. Bristol-Myers Squibb Company (Celgene) Business Overview
 Table 48. Bristol-Myers Squibb Company (Celgene) Cell Theraputics Product
 Table 49. Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 50. Bristol-Myers Squibb Company (Celgene) Recent Development
 Table 51. Bluebird Bio Company Details
 Table 52. Bluebird Bio Business Overview
 Table 53. Bluebird Bio Cell Theraputics Product
 Table 54. Bluebird Bio Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 55. Bluebird Bio Recent Development
 Table 56. Crispr Therapeutics Company Details
 Table 57. Crispr Therapeutics Business Overview
 Table 58. Crispr Therapeutics Cell Theraputics Product
 Table 59. Crispr Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 60. Crispr Therapeutics Recent Development
 Table 61. Roche (Spark Therapeutics) Company Details
 Table 62. Roche (Spark Therapeutics) Business Overview
 Table 63. Roche (Spark Therapeutics) Cell Theraputics Product
 Table 64. Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 65. Roche (Spark Therapeutics) Recent Development
 Table 66. PTC Therapeutics Company Details
 Table 67. PTC Therapeutics Business Overview
 Table 68. PTC Therapeutics Cell Theraputics Product
 Table 69. PTC Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 70. PTC Therapeutics Recent Development
 Table 71. Moderna Therapeutics Company Details
 Table 72. Moderna Therapeutics Business Overview
 Table 73. Moderna Therapeutics Cell Theraputics Product
 Table 74. Moderna Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 75. Moderna Therapeutics Recent Development
 Table 76. Quanterix Company Details
 Table 77. Quanterix Business Overview
 Table 78. Quanterix Cell Theraputics Product
 Table 79. Quanterix Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 80. Quanterix Recent Development
 Table 81. Brainstorm Cell Therapeutics Inc. Company Details
 Table 82. Brainstorm Cell Therapeutics Inc. Business Overview
 Table 83. Brainstorm Cell Therapeutics Inc. Cell Theraputics Product
 Table 84. Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 85. Brainstorm Cell Therapeutics Inc. Recent Development
 Table 86. Lineage Cell Therapeutics Company Details
 Table 87. Lineage Cell Therapeutics Business Overview
 Table 88. Lineage Cell Therapeutics Cell Theraputics Product
 Table 89. Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 90. Lineage Cell Therapeutics Recent Development
 Table 91. Cti Biopharma Company Details
 Table 92. Cti Biopharma Business Overview
 Table 93. Cti Biopharma Cell Theraputics Product
 Table 94. Cti Biopharma Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 95. Cti Biopharma Recent Development
 Table 96. Atara Biotherapeutics, Inc Company Details
 Table 97. Atara Biotherapeutics, Inc Business Overview
 Table 98. Atara Biotherapeutics, Inc Cell Theraputics Product
 Table 99. Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 100. Atara Biotherapeutics, Inc Recent Development
 Table 101. Adaptimmune Company Details
 Table 102. Adaptimmune Business Overview
 Table 103. Adaptimmune Cell Theraputics Product
 Table 104. Adaptimmune Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 105. Adaptimmune Recent Development
 Table 106. Novartis Company Details
 Table 107. Novartis Business Overview
 Table 108. Novartis Cell Theraputics Product
 Table 109. Novartis Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 110. Novartis Recent Development
 Table 111. Gilead Sciences Company Details
 Table 112. Gilead Sciences Business Overview
 Table 113. Gilead Sciences Cell Theraputics Product
 Table 114. Gilead Sciences Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 115. Gilead Sciences Recent Development
 Table 116. Juno Therapeutics Company Details
 Table 117. Juno Therapeutics Business Overview
 Table 118. Juno Therapeutics Cell Theraputics Product
 Table 119. Juno Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 120. Juno Therapeutics Recent Development
 Table 121. Takeda Pharmaceuticals Company Details
 Table 122. Takeda Pharmaceuticals Business Overview
 Table 123. Takeda Pharmaceuticals Cell Theraputics Product
 Table 124. Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 125. Takeda Pharmaceuticals Recent Development
 Table 126. Celgene Company Details
 Table 127. Celgene Business Overview
 Table 128. Celgene Cell Theraputics Product
 Table 129. Celgene Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 130. Celgene Recent Development
 Table 131. Adaptimmune Therapeutics Company Details
 Table 132. Adaptimmune Therapeutics Business Overview
 Table 133. Adaptimmune Therapeutics Cell Theraputics Product
 Table 134. Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 135. Adaptimmune Therapeutics Recent Development
 Table 136. CARsgen Therapeutics Company Details
 Table 137. CARsgen Therapeutics Business Overview
 Table 138. CARsgen Therapeutics Cell Theraputics Product
 Table 139. CARsgen Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 140. CARsgen Therapeutics Recent Development
 Table 141. Precision Biosciences Company Details
 Table 142. Precision Biosciences Business Overview
 Table 143. Precision Biosciences Cell Theraputics Product
 Table 144. Precision Biosciences Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 145. Precision Biosciences Recent Development
 Table 146. Sangamo Therapeutics Company Details
 Table 147. Sangamo Therapeutics Business Overview
 Table 148. Sangamo Therapeutics Cell Theraputics Product
 Table 149. Sangamo Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
 Table 150. Sangamo Therapeutics Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Cell Theraputics Picture
 Figure 2. Global Cell Theraputics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell Theraputics Market Share by Type: 2024 VS 2031
 Figure 4. Stem Cells Features
 Figure 5. Immunocyte Features
 Figure 6. Global Cell Theraputics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cell Theraputics Market Share by Application: 2024 VS 2031
 Figure 8. Allogeneic Cell Therapy Case Studies
 Figure 9. Autologous Cell Therapy Case Studies
 Figure 10. Xenogeneic Cell Therapy Case Studies
 Figure 11. Cell Theraputics Report Years Considered
 Figure 12. Global Cell Theraputics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cell Theraputics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cell Theraputics Market Share by Region: 2024 VS 2031
 Figure 15. Global Cell Theraputics Market Share by Players in 2024
 Figure 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cell Theraputics Revenue in 2024
 Figure 18. North America Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cell Theraputics Market Share by Country (2020-2031)
 Figure 20. United States Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell Theraputics Market Share by Country (2020-2031)
 Figure 24. Germany Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell Theraputics Market Share by Region (2020-2031)
 Figure 32. China Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell Theraputics Market Share by Country (2020-2031)
 Figure 40. Mexico Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell Theraputics Market Share by Country (2020-2031)
 Figure 44. Turkey Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Bristol-Myers Squibb Company (Celgene) Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 48. Bluebird Bio Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 49. Crispr Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 50. Roche (Spark Therapeutics) Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 51. PTC Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 52. Moderna Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 53. Quanterix Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 54. Brainstorm Cell Therapeutics Inc. Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 55. Lineage Cell Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 56. Cti Biopharma Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 57. Atara Biotherapeutics, Inc Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 58. Adaptimmune Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 59. Novartis Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 60. Gilead Sciences Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 61. Juno Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 62. Takeda Pharmaceuticals Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 63. Celgene Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 64. Adaptimmune Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 65. CARsgen Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 66. Precision Biosciences Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 67. Sangamo Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Cell Therapy Market Insights Forecast to 2030
Global Cell Transplantatio Therapy Market Insights Forecast to 2030
Global Cellular Therapy Products Market Research Report 2024
Global Cellular Therapy CT Market Insights Forecast to 2030
Global Adoptive Cell Therapy Market Insights Forecast to 2030
Global Cell Immunotherapy Platform Market Research Report 2024
Global Cell therapy platform Market Research Report 2024
Global Cell Therapy and Tissue Engineering Market Insights Forecast to 2030
Global Cytotherapy Market Insights Forecast to 2030
Cell Transplant Market
Global Universal Cell Therapy Drug Market Research Report 2024
Global iPSC Cell Therapies Market Research Report 2025
Global T Cell Immunotherapy Market Research Report 2025
Global CAR T Cell Immunotherapy Market Insights Forecast to 2030
Global Cell Therapy Regenerative Medicine Market Research Report 2025
Global Cell Therapy Manufacturing Platform Market Research Report 2024
Global Advanced Cell Therapies Market Research Report 2024
Global Cell and Gene Therapy Services Market Research Report 2024
Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno Cell Therapy Market Research Report 2024

RELATED REPORTS

Global BYOD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11T6229
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Z5964
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11S6221
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Point of Sale Automation System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11J6299
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions